Yao JC, Hassan M, Phan A, et al. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008;26:3063–72.

Article  PubMed  Google Scholar 

Masui T, Ito T, Komoto I, et al. Recent epidemiology of patients with gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NEN) in Japan: a population-based study. BMC Cancer. 2020;20:1104.

Article  PubMed  PubMed Central  Google Scholar 

Ito T, Igarashi H, Nakamura K, et al. Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis. J Gastroenterol. 2015;50:58–64.

Article  PubMed  Google Scholar 

Dasari A, Shen C, Halperin D, et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 2017;3:1335–42.

Article  PubMed  PubMed Central  Google Scholar 

Gill A, Klimstra D, Lam A, et al. WHO classification of tumours: Digestive system tumours. 5th ed. Lyon: International Agency for Research on Cancer; 2019.

Google Scholar 

Fujimori N, Miki M, Lee L, et al. Natural history and clinical outcomes of pancreatic neuroendocrine neoplasms based on the WHO 2017 classification; a single-center experience of 30 years. Pancreatology. 2020;20:709–15.

Article  PubMed  Google Scholar 

Ito T, Masui T, Komoto I, et al. JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis. J Gastroenterol. 2021;56:1033–44.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Miki M, Oono T, Fujimori N, et al. CLEC3A, MMP7, and LCN2 as novel markers for predicting recurrence in resected G1 and G2 pancreatic neuroendocrine tumors. Cancer Med. 2019;8:3748–60.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gao H, Liu L, Wang W, et al. Novel recurrence risk stratification of resected pancreatic neuroendocrine tumor. Cancer Lett. 2018;412:188–93.

Article  CAS  PubMed  Google Scholar 

Ye L, Ye H, Zhou Q, et al. A retrospective cohort study of pancreatic neuroendocrine tumors at single institution over 15 years: New proposal for low- and high-grade groups, validation of a nomogram for prognosis, and novel follow-up strategy for liver metastases. Int J Surg. 2016;29:108–17.

Article  PubMed  Google Scholar 

Landoni L, Marchegiani G, Pollini T, et al. The evolution of surgical strategies for pancreatic neuroendocrine tumors (Pan-NENs): time-trend and outcome analysis from 587 consecutive resections at a high-volume institution. Ann Surg. 2019;269:725–32.

Article  PubMed  Google Scholar 

Yamamoto Y, Okamura Y, Uemura S, et al. Vascularity and tumor size are significant predictors for recurrence after resection of a pancreatic neuroendocrine tumor. Ann Surg Oncol. 2017;24:2363–70.

Article  PubMed  Google Scholar 

Hashim YM, Trinkaus KM, Linehan DC, et al. Regional lymphadenectomy is indicated in the surgical treatment of pancreatic neuroendocrine tumors (PNETs). Ann Surg. 2014;259:197–203.

Article  PubMed  Google Scholar 

Li Y, Fan G, Yu F, et al. Meta-analysis of prognostic factors for recurrence of resected well-differentiated pancreatic neuroendocrine tumors. Neuroendocrinology. 2021;111:1231–7.

Article  CAS  PubMed  Google Scholar 

Tsutsumi K, Ohtsuka T, Fujino M, et al. Analysis of risk factors for recurrence after curative resection of well-differentiated pancreatic neuroendocrine tumors based on the new grading classification. J Hepatobiliary Pancreat Sci. 2014;21:418–25.

Article  PubMed  Google Scholar 

Kaneko H, Umakoshi H, Ogata M, et al. Machine learning based models for prediction of subtype diagnosis of primary aldosteronism using blood test. Sci Rep. 2021;11:9140.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kaneko H, Umakoshi H, Ogata M, et al. Machine learning-based models for predicting clinical outcomes after surgery in unilateral primary aldosteronism. Sci Rep. 2022;12:5781.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou RQ, Ji HC, Liu Q, et al. Leveraging machine learning techniques for predicting pancreatic neuroendocrine tumor grades using biochemical and tumor markers. World J Clin Cases. 2019;7:1611–22.

Article  PubMed  PubMed Central  Google Scholar 

Luo Y, Chen X, Chen J, et al. Preoperative prediction of pancreatic neuroendocrine neoplasms grading based on enhanced computed tomography imaging: validation of deep learning with a convolutional neural network. Neuroendocrinology. 2020;110:338–50.

Article  CAS  PubMed  Google Scholar 

Song Y, Gao S, Tan W, et al. Multiple machine learnings revealed similar predictive accuracy for prognosis of PNETs from the surveillance, epidemiology, and end result database. J Cancer. 2018;9:3971–8.

Article  PubMed  PubMed Central  Google Scholar 

Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95: 103208.

Article  PubMed  PubMed Central  Google Scholar 

Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377–81.

Article  PubMed  Google Scholar 

Murakami M, Fujimori N, Matsumoto K, et al. A clinical analysis on functioning pancreatic neuroendocrine tumors (focusing on VIPomas): a single-center experience. Endocr J. 2022. https://doi.org/10.1507/endocrj.EJ22-0111.

Article  PubMed  Google Scholar 

van Buuren S, Groothuis-Oudshoorn K. Mice: multivariate imputation by chained equations in R. J Stat Softw. 2011;45:1–67.

Article  Google Scholar 

Harrell FE Jr, Califf RM, Pryor DB, et al. Evaluating the yield of medical tests. JAMA. 1982;247:2543–6.

Article  PubMed  Google Scholar 

Kamarudin AN, Cox T, Kolamunnage-Dona R. Time-dependent ROC curve analysis in medical research: current methods and applications. BMC Med Res Methodol. 2017;17:53.

Article  PubMed  PubMed Central  Google Scholar 

Kronek LP, Reddy A. Logical analysis of survival data: Prognostic survival models by detecting high-degree interactions in right-censored data. Bioinformatics. 2008;24:i248–53.

Article  PubMed  Google Scholar 

Chen J, Yang Y, Liu Y, et al. Prognosis analysis of patients with pancreatic neuroendocrine tumors after surgical resection and the application of enucleation. World J Surg Oncol. 2021;19:11.

Article  PubMed  PubMed Central  Google Scholar 

Zheng-Pywell R, Fang A, AlKashash A, et al. Prognostic impact of tumor size on pancreatic neuroendocrine tumor recurrence may have racial variance. Pancreas. 2021;50:347–52.

Article  PubMed  PubMed Central  Google Scholar 

Zhang XF, Wu Z, Cloyd J, et al. Margin status and long-term prognosis of primary pancreatic neuroendocrine tumor after curative resection: results from the US neuroendocrine tumor study group. Surgery. 2019;165:548–56.

Article  PubMed  Google Scholar 

Kwon W, Jang JY, Song KB, et al. Risk factors for recurrence in pancreatic neuroendocrine tumor and size as a surrogate in determining the treatment strategy: a Korean nationwide study. Neuroendocrinology. 2021;111:794–804.

Article  CAS  PubMed  Google Scholar 

Dong DH, Zhang XF, Lopez-Aguiar AG, et al. Resection of pancreatic neuroendocrine tumors: defining patterns and time course of recurrence. HPB (Oxford). 2020;22:215–23.

Article  PubMed  Google Scholar 

Marchegiani G, Landoni L, Andrianello S, et al. Patterns of recurrence after resection for pancreatic neuroendocrine tumors: who, when, and where? Neuroendocrinology. 2019;108:161–71.

Article  CAS  PubMed  Google Scholar 

Jilesen AP, van Eijck CH, in’t Hof KH, et al. Postoperative complications, in-hospital mortality and 5-year survival after surgical resection for patients with a pancreatic neuroendocrine tumor: a systematic review. World J Surg. 2016;40:729–48.

Article  PubMed  Google Scholar 

Sadot E, Reidy-Lagunes DL, Tang LH, et al. Observation versus resection for small asymptomatic pancreatic neuroendocrine tumors: a matched case-control study. Ann Surg Oncol. 2016;23:1361–70.

Article  PubMed  Google Scholar 

Breiman L. Random forests. Mach Learn. 2001;45:5–32.

Article  Google Scholar 

Ishwaran H, Kogalur UB, Blackstone EH, et al. Random survival forests. Ann Appl Stat. 2008. https://doi.org/10.1214/08-AOAS169.

Article  Google Scholar 

Sakin A, Tambas M, Secmeler S, et al. Factors affecting survival in neuroendocrine tumors: a 15-year single center experience. Asian Pac J Cancer Prev. 2018;19:3597–603.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee L, Igarashi H, Fujimori N, et al. Long-term outcomes and prognostic factors in 78 Japanese patients with advanced pancreatic neuroendocrine neoplasms: a single-center retrospective study. Jpn J Clin Oncol. 2015;45:1131–8.

PubMed  PubMed Central